177Lu-FAP-2286 Combined Chemotherapy in a Case of Thymus Nonkeratinizing Squamous Carcinoma With Superior Vena Cava Syndrome
Abstract
We reported a 52-year-old man with thymus nonkeratinized squamous carcinoma presenting with acute superior vena cava syndrome (SVCS) who received 177 Lu-FAP-2286 treatment and followed by low-dose chemotherapy. 68 Ga-FAP-2286 PET/CT revealed significantly less intensity of the mediastinal mass comparing to pretherapy scan, as well as significant relief of SVCS. No adverse effects were observed.
Fields of Study & Subjects
Peptidase Inhibition and Analysis
Radiopharmaceutical Chemistry and Applications
Myasthenia Gravis and Thymoma
Publication details
- Journal / source
- Clinical Nuclear Medicine
- Volume
- 51
- Issue
- 6
- Pages
- 509–510
- Publication date
- 3 February 2026
- Language
- EN